Last reviewed · How we verify

NCT04206930: ALEXART

Impact of Art Therapy on Alexithymia in People With Alcohol Use Disorder

Status unknown NA Last updated 20 December 2019
What this trial tests

NA trial testing Art Therapy in Alexithymia in 128 participants. Status unknown.

Timeline
13 December 2019
Primary endpoint
7 January 2020
13 December 2022

Quick facts

Lead sponsorUniversity Hospital, Angers
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment128
Start date13 December 2019
Primary completion7 January 2020
Estimated completion13 December 2022
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Angers

Who can join

Adults 18 to 75, any sex, with Alexithymia or Alcohol Use Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Art therapy support combined with standard care for people with an alcohol use disorder coming to a day hospital for withdrawal could be beneficial compared to standard care alone because it would improve the alexithymia of these patients, helping them to better identify their feelings and / or emotions, and improve their self-confidence, their self-esteem self and their oral communication.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Art Therapy

Trials testing the same drug.

Other University Hospital, Angers trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04206930.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing